//

News

Filter by Category

All Blog News Podcasts Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

April 14, 2025

C-Path Honors Memory, Legacy of Beloved CP-RND Member and ALS Patient Advocate Layne Oliff

Critical Path Institute (C-Path) mourns the loss of one of its ALS community members, Layne Oliff. Layne, who passed on Friday, Ap

April 9, 2025-April 10, 2025

2025 Clinical Outcome Assessment Program Annual Meeting Recap

On April 9-10, 2025, the 2025 Clinical Outcome Assessment...

April 11, 2025

C-Path Launches Newest Podcast Episode: Connecting the Dots Between T1D and Parkinson’s

In our latest episode of the C-Path podcast, “Connecting the Dots Between Type 1 Diabetes and Parkinson’s Disease,” we...

April 2, 2025

C-Path’s Stephenson Appears on Xtalks’ Life Science Podcast to Talk Future of Drug Development in Parkinson’s, Alzheimer’s

C-Path's Diane Stephenson recently appeared on the Xtalks Life Science Podcast...

March 10, 2025

C-Path’s Critical Path for Parkinson’s Consortium Welcomes CND Life Sciences

C-Path is excited to welcome CND Life Sciences as the newest member of it Critical Path for Parkinson’s (CPP)...

February 19, 2025

Advancing Neonatal Drug Development Through Collaboration

At C-Path’s INC, we believe that meaningful progress in neonatal drug development...

February 19, 2025

C-Path’s eCOA Consortium Welcomes Veeva Systems and VPG Health as Newest Partners

C-Path's eCOA Consortium is thrilled to welcome Veeva Systems and VPG Health...

February 18, 2025

C-Path’s CPA-1 Consortium Welcomes Newest Members Kamada, Sanofi

Critical Path for Alpha-1 (CPA-1) consortium today announced the addition of biopharmaceutical companies, Kamada and Sanofi.

February 13, 2025

Breaking the silence: challenges and opportunities in pediatric drug development

Pediatric drug development faces signiﬁcant challenges, including underfunding, ethical concerns, and complex regulatory...

January 31, 2025

Integrating Complex In Vitro Models Into the Regulatory Pipeline

C-Path has developed a framework to support FDA qualification of CIVMs for use in regulatory submissions.

Previous12 3...29 Next